DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Drilon AE, Sima CS, Somwar R et al.
Phase II study of cabozantinib for patients with advanced RET-rearranged lung cancers.
J Clin Oncol 2015; (suppl): abstr 8007
33
We do not assume any responsibility for the contents of the web pages of other providers.